MXPA05013771A - Derivados de enalapril-nitroxiderivados y compuestos relacionados como inhibidores de la enzima que convierte la angiotensina para el tratamiento de enfermedades cardiovasculares. - Google Patents

Derivados de enalapril-nitroxiderivados y compuestos relacionados como inhibidores de la enzima que convierte la angiotensina para el tratamiento de enfermedades cardiovasculares.

Info

Publication number
MXPA05013771A
MXPA05013771A MXPA05013771A MXPA05013771A MXPA05013771A MX PA05013771 A MXPA05013771 A MX PA05013771A MX PA05013771 A MXPA05013771 A MX PA05013771A MX PA05013771 A MXPA05013771 A MX PA05013771A MX PA05013771 A MXPA05013771 A MX PA05013771A
Authority
MX
Mexico
Prior art keywords
enalapril
treatment
nitroxyderivatives
derivatives
cardiovascular diseases
Prior art date
Application number
MXPA05013771A
Other languages
English (en)
Inventor
Nicoletta Almirante
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Publication of MXPA05013771A publication Critical patent/MXPA05013771A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Compuestos de formula (I): A-(X1-ONO2)S, en donde A es un inhibidor de la ACE conocido, tal como enalapril y X1 es un separador tal como un alquileno de (C1-C6); la definicion completa de A y X1 se da en la reivindicacion 1; los compuestos pueden utilizarse como inhibidores de la ACE para el tratamiento de enfermedades cardiovasculares y renales y procesos inflamatorios; el ejemplo de formula (1) tiene una activada farmacologica mejorada cuando se compara con el compuesto de la tecnica anterior estrechamente relacionado estructuralmente.
MXPA05013771A 2003-06-19 2004-06-11 Derivados de enalapril-nitroxiderivados y compuestos relacionados como inhibidores de la enzima que convierte la angiotensina para el tratamiento de enfermedades cardiovasculares. MXPA05013771A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03101796 2003-06-19
PCT/EP2004/051089 WO2004110432A1 (en) 2003-06-19 2004-06-11 Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases

Publications (1)

Publication Number Publication Date
MXPA05013771A true MXPA05013771A (es) 2006-03-08

Family

ID=33547744

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05013771A MXPA05013771A (es) 2003-06-19 2004-06-11 Derivados de enalapril-nitroxiderivados y compuestos relacionados como inhibidores de la enzima que convierte la angiotensina para el tratamiento de enfermedades cardiovasculares.

Country Status (18)

Country Link
US (1) US7217733B2 (es)
EP (1) EP1635816B1 (es)
KR (1) KR20060021900A (es)
CN (1) CN1809345A (es)
AR (1) AR044839A1 (es)
AT (1) ATE424199T1 (es)
AU (1) AU2004246821A1 (es)
BR (1) BRPI0411430A (es)
CA (1) CA2529478A1 (es)
DE (1) DE602004019779D1 (es)
ES (1) ES2322263T3 (es)
IL (1) IL172018A0 (es)
MX (1) MXPA05013771A (es)
NO (1) NO20060268L (es)
PL (1) PL379197A1 (es)
RU (1) RU2006100827A (es)
WO (1) WO2004110432A1 (es)
ZA (1) ZA200600526B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2536173A1 (en) * 2003-08-20 2005-03-03 Nitromed, Inc. Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
TW200616604A (en) 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
CA2577490A1 (en) 2004-08-26 2006-03-16 Nicholas Piramal India Limited Prodrugs containing alkyldisulfide linker groups
CA2626568A1 (en) * 2005-10-18 2007-04-26 Nicox S.A. Renin inhibitors nitroderivatives
ES2604562T3 (es) * 2007-02-05 2017-03-07 Nicox Science Ireland Compuestos donantes de óxido nítrico
CA2709071C (en) 2007-12-14 2016-11-15 Labogroup S.A.S. Delivering aerosolizable food products
AR073259A1 (es) * 2008-07-29 2010-10-28 Merck & Co Inc Derivados de furosemida utiles como diureticos
WO2011160974A2 (en) 2010-06-21 2011-12-29 Nicox S.A. Statin derivatives
JO3350B1 (ar) 2011-03-07 2019-03-13 Merck Sharp & Dohme مشتقات حلقية غير متجانسة محتوية على مجموعات أمينو أولية ومركبات داي أزينيومديولات

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4574079A (en) * 1983-05-27 1986-03-04 Gavras Haralambos P Radiolabeled angiotensin converting enzyme inhibitors for radiolabeling mammalian organ sites
IT1276071B1 (it) 1995-10-31 1997-10-24 Nicox Ltd Compositi ad attivita' anti-infiammatoria
IT1295694B1 (it) * 1996-11-14 1999-05-27 Nicox Sa Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica
IT1311923B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1311924B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1314184B1 (it) 1999-08-12 2002-12-06 Nicox Sa Composizioni farmaceutiche per la terapia di condizioni di stressossidativo

Also Published As

Publication number Publication date
ZA200600526B (en) 2007-01-31
US20050004100A1 (en) 2005-01-06
IL172018A0 (en) 2009-02-11
PL379197A1 (pl) 2006-07-24
CN1809345A (zh) 2006-07-26
AR044839A1 (es) 2005-10-05
BRPI0411430A (pt) 2006-07-25
EP1635816A1 (en) 2006-03-22
AU2004246821A1 (en) 2004-12-23
WO2004110432A1 (en) 2004-12-23
ATE424199T1 (de) 2009-03-15
KR20060021900A (ko) 2006-03-08
NO20060268L (no) 2006-03-15
EP1635816B1 (en) 2009-03-04
CA2529478A1 (en) 2004-12-23
RU2006100827A (ru) 2007-07-27
ES2322263T3 (es) 2009-06-18
US7217733B2 (en) 2007-05-15
DE602004019779D1 (de) 2009-04-16

Similar Documents

Publication Publication Date Title
BG108806A (en) IIb/IIIa CELL ADHESION INHIIBITORS, METHOD FOR THE PRODUCTION, PHARMACEUTCIAL COMPOSITION AND ADMINISTRATION THEREOF
EA200100934A1 (ru) Применение ингибиторов cyp2d6 в комбинированных способах лечения
AU2003264060A1 (en) Phenacyl xanthine derivatives as dpp-iv inhibitor
WO2003002553A3 (en) Fluoropyrrolidines as dipeptidyl peptidase inhibitors
HK1057899A1 (en) Arylmethylamine derivatives for use as tryptase inhibitors
DE69818049D1 (de) Inhibitoren der alpha4-beta1 vermittelten zelladhäsion
WO2003002531A3 (en) Fluoropyrrolidines as dipeptidyl peptidase inhibitors
RO117913B1 (ro) Derivaţi de n-[(amino-(imino)metil)fenil]propil amide substituite, compoziţie farmaceutică care îi conţine şi metodă de tratament
WO2003002530A3 (en) Pyrrolidines as dipeptidyl peptidase inhibitors
ATE331708T1 (de) Substituierte 3-alkyl- und 3-arylalkyl-1h-indol-1-yl-essigsäure-derivate als plasminogen aktivator inhibitor-1 (pai-1) inhibitoren
HK1087702A1 (en) Arylmethylamine derivatives for use as tryptase inhibitors
MXPA02011376A (es) Benzofenonas como inhibidores de il-1beta y tnf-alfa.
BG103995A (en) Reverse hydroxamate inhibitors of matrix metalloprreverse hydroxamate inhibitors of matrix metallprooteinases teinases
TW200510311A (en) CCr8 inhibitors
MXPA05010433A (es) Derivados de pirrolidina y procedimiento para prepararlos.
EE200100355A (et) Rakkude adhesiooni inhibeerivad põletikuvastased ja immunosupressiivsed ühendid
NO20060268L (no) Enalapril-nitroksyderivater og beslektede forbindelser som ACE-inhibitorer for behandling av kardiovaskulaere sykdommer
WO2001092253A3 (en) Inhibitors of alpha l beta 2 mediated cell adhesion
MX2007006279A (es) Composiciones farmaceuticas que comprenden inhibidores de nep, inhibidores del sistema de produccion de endotelina endogena, e inhibidores de hmg coa-reductasa.
AU4651700A (en) Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
MY141020A (en) Novel pparalpha and ppargamma agonists
WO2000040583A3 (de) Imidazo[4,5-c]-pyridin-4-on-derivate
TW200503703A (en) Pharmaceutical compositions
AU2003242592A1 (en) Amide derivatives as inhibitors of the enzymatic activity of renin
EA200000205A1 (ru) Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов

Legal Events

Date Code Title Description
FG Grant or registration